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The serine/threonine kinase Stk and 
the phosphatase Stp regulate cell 
wall synthesis in Staphylococcus 
aureus
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Christian Stigloher  6, Mirco Steger7, Andreas Schlosser7 & Knut Ohlsen1
The cell wall synthesis pathway producing peptidoglycan is a highly coordinated and tightly regulated 
process. Although the major components of bacterial cell walls have been known for decades, the 
complex regulatory network controlling peptidoglycan synthesis and many details of the cell division 
machinery are not well understood. The eukaryotic-like serine/threonine kinase Stk and the cognate 
phosphatase Stp play an important role in cell wall biosynthesis and drug resistance in S. aureus. 
We show that stp deletion has a pronounced impact on cell wall synthesis. Deletion of stp leads to a 
thicker cell wall and decreases susceptibility to lysostaphin. Stationary phase Δstp cells accumulate 
peptidoglycan precursors and incorporate higher amounts of incomplete muropeptides with non-
glycine, monoglycine and monoalanine interpeptide bridges into the cell wall. In line with this cell wall 
phenotype, we demonstrate that the lipid II:glycine glycyltransferase FemX can be phosphorylated 
by the Ser/Thr kinase Stk in vitro. Mass spectrometric analyses identify Thr32, Thr36 and Ser415 as 
phosphoacceptors. The cognate phosphatase Stp dephosphorylates these phosphorylation sites. 
Moreover, Stk interacts with FemA and FemB, but is unable to phosphorylate them. Our data indicate 
that Stk and Stp modulate cell wall synthesis and cell division at several levels.
Staphylococcus aureus is an opportunistic pathogen that inhabits the human skin and mucosa and causes a large 
variety of nosocomial and community-acquired infections1. Nowadays, it is difficult to treat S. aureus infections 
because S. aureus has acquired resistance to multiple drugs, including penicillin, methicillin and vancomycin2. 
Therefore, there is a need for new antimicrobial drugs against S. aureus and its multiple antibiotic-resistant 
strains. The most promising strategy to combat antibiotic resistance is to find novel antibiotics which interfere 
with the cell wall biosynthesis pathway3.
The bacterial cell envelope is essential for survival and pathogenicity. It forms a barrier against environmental 
stresses and contributes to virulence and antibiotic resistance. The cell wall of gram-positive bacteria is composed 
of a multi-layered mesh of cross-linked peptidoglycan (PGN). PGN consists of chains of repeating disaccharide 
units comprising N-acetylglucosamine (GlcNAc) and N-acetylmuramic acid (MurNAc). The lactoyl group of 
MurNAc is supplemented with a penta stem peptide (L-Ala-D-isoGlu-L-Lys-D-Ala-D-Ala). The staphylococcal 
PGN polysaccharide chains are highly cross-linked via interpeptide bridges of five glycyl residues protruding 
from the L-lysine of the stem-peptides4. These interpeptide bridges are synthesized by the FemX/A/B enzymes5. 
The overall PGN synthesis can be divided into three distinct stages: (1) formation of the nucleotide sugar-linked 
UDP-MurNAc-pentapeptide (Park’s Nucleotide), (2) transfer of the soluble PGN precursor to the lipid carrier 
undecaprenyl-diphosphate (resulting lipid I) and addition of UDP-GlcNAc, finally yielding lipid II, and (3) 
transport of this complete subunit across the cytoplasmic membrane and incorporation into the growing PGN 
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sacculus mainly by penicillin-binding proteins6. At this final stage, cross-bridge formation occurs together with 
secondary modification of the newly synthesized PGN. An overview of the PGN synthesis pathway is shown in 
Fig. 1.
The cell wall synthesis pathway producing PGN is highly coordinated and tightly regulated7. There are several 
reports showing that next to two-component systems8,9, serine/threonine phosphorylation plays an important 
role in cell wall metabolism10,11. In S. aureus the conserved eukaryotic-like serine/threonine kinase Stk (alterna-
tively named as PknB or Stk1) and the cognate phosphatase Stp impact bacterial cell signalling, central metabo-
lism12–14, stress response15,16, antibiotic resistance16–18 and virulence16,17,19–21. Recently, pentaglycine-lipid II has 
been found to serve as a signal for activation of serine/threonine kinase Stk of S. aureus9. Pentaglycine-lipid 
II interacts with the extracellular PASTA (penicillin binding protein and serine/threonine kinase associated) 
domains of Stk and triggers its kinase activity in vitro9. In fact, deletion of stp and stk in S. aureus causes cell 
division defects resulting in the formation of multiple and incomplete septa, differences in cell size and cell wall 
thickness10,22. In addition, stk and stk/stp deletion strains are more susceptible to cell wall-acting antibiotics like 
tunicamycin12, fosfomycin12,20 and β-lactam antibiotics10,16. Moreover, the phosphatase Stp contributes to reduced 
susceptibility to vancomycin and enhanced virulence23. Furthermore, Stk cross-talks with two-component sys-
tems involved in cell wall metabolism by phosphorylation of the response regulator of VraTSR8, WalRK9 and 
GraSR24, affecting the expression of the cell wall stimulon and cell wall hydrolases as well as the cell wall charge. 
There are also studies which have shown that Stk homologs regulate cell wall synthesis and cell division in 
Streptococcus25–28, Bacillus29,30, Enterococcus31 and Streptomyces32.
However, there is still a lack of knowledge about the Stk- and Stp-dependent regulation in cell physiology. In 
this study, we specify the role of Stk and Stp in regulating cell wall synthesis by analysis of the cell wall phenotype 
of stk, stp, and stk/stp mutant strains. Deletion of stp leads to a thicker cell wall with incomplete muropeptides and 
reduced susceptibility to lysostaphin. In addition, we discover that the essential cell wall synthesis enzyme FemX 
Figure 1. Peptidoglycan synthesis pathway of S. aureus. The PGN synthesis of S. aureus starts with 
glucosamine-6-phosphate (GlcN6P) as the central metabolite controlling cell wall synthesis and glycolysis. 
The aminotransferase GlmS converts fructose-6- phosphate (F6P) into GlcN6P using glutamine as a nitrogen 
source. GlcN6P is processed to N-acetylglucosamine (UDP-GlcNAc) by the activity of the phosphoglucosamine 
mutase GlmM and the uridyltransferase GlmU60. The conversion of UDP-GlcNAc to N-acetylmuramic acid 
(UDP-MurNAc) is catalyzed by MurA and MurB. Mur ligases (MurC-F) sequentially add the amino acids 
L-Ala, D-Glu, and L-Lys and the dipeptide D-Ala-D-Ala to UDP-MurNAc, yielding Park’s nucleotide (UDP-
MurNAc-L-Ala-D-Glu-L-Lys-D-Ala-D-Ala). This soluble PGN precursor is then linked to the lipid carrier 
undecaprenyl-diphosphate via the membrane translocase MraY, producing membrane-bound lipid I. The 
membrane glycosyltransferase MurG links UDP-GlcNAc to the lipid I molecule, yielding lipid II (undecaprenyl-
diphosphate-GlcNAc-MurNAc-pentapeptide). In S. aureus, lipid II is further modified by the addition of five 
glycine residues catalyzed by the FemX/A/B proteins. These non-ribosomal peptidyl-transferases use glycyl-
tRNAs to sequentially add five glycine’s to the PGN-lysyl side chain of lipid II61. FemX62,63 adds the first glycyl 
unit, FemA63,64 the second and third unit, and FemB40,63 adds the fourth and fifth glycyl unit to complete the 
pentaglycine-bridge. After specific modifications such as deamination of D-Glu of the stem peptide by  
MurT/GatD65,66, the pentaglycine-lipid II unit is translocated from the inner side to the outer side of the 
membrane. As the final stage of PGN synthesis, penicillin binding proteins (Pbp) incorporate extracellular lipid 
II into the growing PGN sacculus through transglycosylation and transpeptidation.
www.nature.com/scientificreports/
3SCIenTIFIC REPORTS |  (2018) 8:13693  | DOI:10.1038/s41598-018-32109-7
is a target of Stk and Stp. Moreover, we show that Stk interacts with FemA/B and other cell wall synthesis and cell 
division proteins.
Results
stp deletion leads to an altered muropeptide composition in the stationary phase. To deter-
mine the role of Stk and Stp in cell wall metabolism we analysed morphological differences and the cell wall com-
position of S. aureus NewmanHG wild type and stk, stp and stk/stp deletion strains (Δstk, Δstp, and ΔstkΔstp) in 
logarithmic and stationary phase cultures. First, we investigated the cell wall morphology of the deletion strains 
in S. aureus NewmanHG background by TEM, since previous reports have demonstrated severe cell wall struc-
tural alteration in S. aureus strains N31510 and MW222. In the stationary phase, stk and stk/stp mutant cells were 
up to 15% larger in diameter than wild type cells. In contrast, stp mutant cells were 4% smaller (Fig. 2a) in the 
stationary phase than wild type cells. Logarithmic phase cells were generally larger (10%) than stationary phase 
cells. In the logarithmic phase, Δstk, Δstp and ΔstkΔstp were significantly larger than wild type cells (8%, 7% and 
16%, respectively) (Fig. S1a). The cell walls of stationary phase stp mutant cells were significantly thicker (38%) 
compared to the other strains (Fig. 2a). In logarithmic phase, the cell wall of Δstk was significantly thinner (23%), 
whereas the cell wall of Δstp was thicker (26%) than the one of the wild type strain or double mutant (Fig. S1a). 
Moreover, we observed morphological alterations like detached cell wall or membrane-like fragments in Δstk 
and ΔstkΔstp cells particularly at logarithmic phase. A similar observation was reported previously for stationary 
phase cells in another strain background10. The most prominent result to emerge from these electron microscopy 
data is the thicker cell wall of the stp deletion strain.
To identify molecular patterns associated with the observed changes in cell wall thickness, we isolated PGN of 
all four strains and digested it with the muramidase mutanolysin, which hydrolyses the sugar chains into disac-
charides. The resulting muropeptides were analysed by UPLC as well as by UPLC-MS. This enabled us to directly 
determine the masses and the potential structures of the muropeptide peaks (Fig. S2a). The muropeptide chroma-
tograms of all strains at both growth phases were virtually the same (Fig. S1b), with only one exception: There was 
a strong increase of several muropeptide peaks of PGN isolated from the stp mutant in stationary phase (Fig. 2b,c). 
UPLC-MS analysis proved that this strain still synthesized classical muropeptides: the monomer Penta-Gly5 (peak 
3), the cross-linked dimer Penta-Gly5-Tetra-Gly5 (peak 6) and trimer Penta-Gly5-Tetra-Gly5-Tetra-Gly5 (peak 
9). However, we found additional muropeptides with changes within the interpeptide bridge in stationary Δstp 
cells. Either the pentaglycine was exchanged by a single glycine (peak 2: Penta-Gly), by alanine (peak 4: Penta-Ala 
and peak 7: Penta-Gly5-Tetra-Ala) or by Ala-Gly (peak 10: Penta-Gly5-Tetra-Gly5-Tetra-Ala-Gly). Moreover, 
one pentaglycine bridge was missing completely, as in peak 1 (Penta), peak 5 (Penta-Gly5-Tetra) and peak 8 
(Penta-Gly5-Tetra-Gly5-Tetra). When we searched for the respective masses of these incomplete muropeptides in 
the other strains, they were much less abundant or even non-detectable (Fig. S2b). In contrast, the amount of the 
classical muropeptides was within the same range in all four strains tested in both growth phases. Importantly, 
incomplete muropeptides were accumulated exclusively in stationary stp mutant cells compared to all three other 
strains (Fig. S2b). This shows that the incomplete muropeptides are caused by the stp deletion. The PGN of S. 
aureus is highly cross-linked. The amount of PGN cross-linking was not significantly different in any of the four 
strains showed no significant differences (Fig. S2c) and was within the typical range (73%)5. There were no differ-
ences in the muropeptide composition of the stp strain regarding deacetylation of the sugar moieties or amidation 
of glutamate compared to the wild type strains.
S. aureus Δstp is less susceptible to lysostaphin. Based on the altered cell wall thickness and cell 
wall composition of the Δstp strain, we suspected that deletion of stp directly affected the stability of the cell 
wall. Therefore we determined the susceptibility of each strain to the glycyl-glycine endopeptidase lysostaphin by 
measuring the decline in optical cell density. The Δstp strain was less susceptible to lysostaphin compared to the 
other strains at both growth conditions (Fig. 2d). After lysostaphin treatment of stationary phase cells, the Δstp 
strain reached 50% lysis later (85 min) compared to wt, Δstk and ΔstkΔstp strain (35 min). During the logarith-
mic phase (Fig. S1d), Δstp cells needed 78 min, Δstk needed 60 min, wild type and ΔstkΔstp needed 35 min to 
reach 50% lysis due to lysostaphin treatment. Interestingly, in the logarithmic phase the Δstp strain was more sus-
ceptible to lysostaphin (78 min) compared to stationary phase Δstp (85 min). The most striking result to emerge 
from the data is the reduced lysostaphin susceptibility of Δstp mutant in both growth phases.
stp deletion leads to accumulation of cell wall metabolites. In order to explain the muropeptide 
diversity of the thick cell wall phenotype of Δstp, the cell wall metabolites were investigated in all strains using 
LC-MS. All soluble cell wall precursors, beginning with UDP-GlcNAc and UDP-MurNAc and ending with Park’s 
Nucleotide (UDP-MurNAc-Ala-Glu-Lys-Ala-Ala), were detected in all strains in both growth conditions. The 
significant differences between wild type and Δstk or Δstp mutant strains in logarithmic and stationary phase 
cells are discussed below (Figs 3 and S3). As expected, the abundance of cell wall metabolites was higher in 
the logarithmic phase- than in stationary phase cells (Fig. S3). In logarithmic phase cells, UDP-GlcNAc (2.336 
to 3.103) was the most abundant cell wall precursor in all strains. In contrast, UDP-MurNAc-Ala-Glu-Lys 
(0.003 to 0.008) was less abundant in all strains in the logarithmic phase (Fig. S3a). In stationary phase cells, 
all cell wall precursors, with the exception of UDP-MurNAc (0.048 to 0.799), were less abundant (Fig. S3b). 
UDP-MurNAc-Ala-Glu-Lys was below the detection limit in stationary phase cells.
As shown in Fig. S3c, Δstk and ΔstkΔstp strains in the logarithmic phase showed a significant accumu-
lation of UDP-MurNAc-Ala (6.0- and 6.5-fold, respectively) and UDP-MurNAc-Ala-Glu (2.6- and 2.3-fold, 
respectively) in comparison to wild type cells. The cell wall precursors UDP-MurNAc-Ala-Glu-Lys and 
UDP-MurNAc-Ala-Glu-Lys-Ala-Ala of logarithmic Δstk and ΔstkΔstp cells showed no significant changes com-
pared to wild type cells. In contrast, in the stp mutant UDP-MurNAc-Ala (2.3-fold), UDP-MurNAc-Ala-Glu-Lys 
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Figure 2. Cell wall phenotype of S. aureus NewmanHG wt, Δstk, Δstp and ΔstkΔstp strains at stationary 
growth phase. (a) Analysis of cell morphology and cell wall thickness of S. aureus wt and mutant cells at the 
same stage in the cell cycle by TEM. The mean cell diameter (CD) and the cell wall thickness (CWT) was 
assessed based on the diameter of the 20 largest cells out of 100 cells per strain. The CWT was measured at 
five different points on the cell wall. (b) Muropeptide profile of S. aureus wt and mutant strains obtained by 
UPLC-MS. Highlighted muropeptide peaks were identified by MS and their structures are shown in (c). The 
chromatogram of S. aureus Δstp at stationary phase showed an accumulation of monomers (peak 1, 2, 4), 
dimers (peak 5, 7) and trimers (peak 8, 10) with incomplete interpeptide bridges. (d) Lysostaphin susceptibility 
of S. aureus wt and mutant strains. Data represent percentages of the initial optical density (OD600) over three 
hours after treatment with 0.5 µg/ml lysostaphin. The graphs show the mean and standard deviation of three 
independent experiments. Significance values of CD, CWT and lysostaphin susceptibility were calculated using 
a two-tailed unpaired student t-test (*p < 0.05, **p < 0.01, ***p < 0.001).
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(2.0-fold) and UDP-MurNAc-Ala-Glu-Lys-Ala-Ala (2.6-fold) were accumulated significantly in comparison to 
the wild type. In the stationary phase (Figs 3 and S3d), Δstk and ΔstkΔstp strains showed no significant changes 
in cell wall precursor abundance in comparison to wild type cells, with the exception of UDP-MurNAc-Ala-Glu 
(1.5-fold increase) in ΔstkΔstp cells. Interestingly, the Δstp strain showed a significant accumulation of 
UDP-MurNAc (5.5-fold), UDP-MurNAc-Ala (4.6-fold) and UDP-MurNAc-Ala-Glu-Lys-Ala-Ala (3.5-fold). In 
contrast, UDP-MurNAc-Ala-Glu was slightly decreased (1.5-fold) in stationary Δstp cells. The most distinct 
aspect of the metabolomics data is that stp mutant cells accumulate the cell wall precursors UDP-MurNAc-Ala 
to UDP-MurNAc-Ala-Glu-Lys-Ala-Ala in the logarithmic phase and UDP-MurNAc, UDP-MurNAc-Ala and 
UDP-MurNAc-Ala-Glu Lys-Ala-Ala in the stationary phase. On the other hand, in Δstk and ΔstkΔstp mutants 
UDP-MurNAc-Ala and UDP-MurNAc-Ala-Glu accumulate in the logarithmic growth phase, whereas the early 
PGN precursors UDP-GlcNAc and UDP-MurNAc decrease in the stationary growth phase.
Stk interacts with cell wall synthesis- and cell division proteins. Based on the changes in cell wall 
precursor abundance in the mutant strains and the uniquely composed cell wall of Δstp, we speculated that Stk 
and Stp regulate cell wall synthesis enzymes. Thus, we analysed protein-protein interaction of Stk or Stp with cell 
wall synthesis- and cell division proteins using a bacterial two-hybrid system. All protein-protein interactions are 
shown in Figs 4a, S4 and S13 and are summarized in Fig. 4b. The membrane-located kinase Stk dimerized and 
interacted weakly with the cognate phosphatase Stp (Fig. 4a). After 5 days incubation on X-gal indicator plates, 
the weak Stk-Stp interaction was seen in two-thirds of the experiments. Stk interacted with membrane-associated 
cell wall synthesis enzymes (MurG, FemA, FemB, Pbp1, Pbp2 and Pbp3), the cell wall hydrolase LytH, the mono-
functional transglycosylase Mgt, glycosyltransferases (RodA, FtsW) and cell division proteins (DivIB, DivIC, 
EzrA). In this approach, Stk interacted neither with cytosolic cell wall synthesis enzymes (GlmS, GlmM, GlmU, 
MurA-F, MurI, Ddl and FemX) nor with Pbp4, cell wall hydrolases Sle1 and SsaA, the acetyltransferase OatA 
nor cell division-related proteins GpsB and FtsW. The phosphatase Stp did not interact with cell wall synthesis- 
and cell division proteins under the tested conditions. We focused on the interaction of Stk/Stp with FemX/A/B 
enzymes, as the latter produce the pentaglycine-interpeptide bridge of the lipid II molecule. FemX interacted nei-
ther with Stk, Stp, FemA nor FemB. However, FemX interacted weakly with Pbp2, RodA, DivIC and EzrA. FemA 
and FemB interacted with Stk and with cell wall synthesis enzymes (MurG, Pbp1, Pbp2), Mgt, LytH, RodA, FtsW 
and cell division proteins (DivIB, DivIC, EzrA). FemA and FemB interacted with each other and also formed 
homodimers, which was not the case for FemX. Overall, these results indicate that the membrane-associated 
kinase Stk interacts with several cell wall synthesis- and cell division proteins.
Stk and Stp phosphorylate and dephosphorylate FemX. Based on the Stk interaction with FemA/B, 
we speculated that Stk phosphorylates and Stp dephosphorylates the FemX/A/B proteins. Therefore, we per-
formed in vitro kinase- and phosphatase assays with N-terminal polyhistidine-tagged fusion proteins (Fig. 4c). 
Due to the strong degradation of full-length Stk, we used the Stk kinase domain (StkKD) lacking the transmem-
brane and extracellular PASTA domains33. StkKD phosphorylated FemX but not FemA or FemB. Mass spectrom-
etry analysis revealed the Stk-mediated phosphorylation sites on FemX (Fig. S5a–e) as Thr32, Thr36 and Ser415 
(Fig. S5e, peak 4). We detected mono- (Fig. S5e, peak 1 and 2) and diphosphorylated (Fig. S5e, peak 3) phospho-
threonine peptides of FemX. Stp was able to completely dephosphorylate these Stk-mediated phosphorylation 
sites (Figs 4c and S5c). The negative control FemX alone, as well as Stk-FemX without ATP, showed only isolated 
phosphopeptides which were neglectable (Figs 4c and S5a). Western blot and mass spectrometry analysis showed 
that Stk did not phosphorylate FemA and FemB (Figs 4c and S5f–k). These data suggest that Stk phosphorylates 
FemX but not FemA or FemB. Stp dephosphorylates the Stk-mediated phosphorylation sites of FemX.
Figure 3. Stk and Stp affect intracellular peptidoglycan precursor concentration. Bar charts represents the log2-
fold changes of respective metabolites from Δstk, Δstp and ΔstkΔstp mutants compared to wild type cells at 
stationary phase. Significant differences (non-parametric unpaired Mann-Whitney test; *p < 0.05) are marked 
with an asterisk. A alanine, E glutamic acid, K lysine, n.d. not detectable.
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S. aureus Δstk and ΔstkΔstp are more susceptible to cell wall-acting antibiotics. In order 
to localize the potential targets of Stk and Stp in the cell wall biosynthesis pathway, we determined the minimal 
inhibitory concentration (MIC) of cell wall-active antibiotics. We tested the susceptibilities of S. aureus wild type 
and its isogenic mutant strains to ten antibiotics which interfere with different steps of the cell wall synthesis 
pathway (Table S6). The MIC of the inhibitors of the intracellular cell wall precursor synthesis pathway (fosfomy-
cin, D-cycloserine and tunicamycin) observed for the Δstp strain were 2-fold lower as compared to the wild type 
strain. On the other hand, the MIC for the lantibiotic nisin of Δstp was 2-fold higher than the wild type. The other 
cell wall-active antibiotics that we tested did not affect the MIC of the Δstp strain. The MIC of the MurA-inhibitor 
fosfomycin showed a 2-fold increase for the Δstk strain and a 2-fold decrease for the ΔstkΔstp strain compared 
to the wild type. Interestingly, tunicamycin, an inhibitor of MraY translocase, was 8-fold more active against Δstk 
(as already described by Donat et al.12 in the strain 8325 background) and ΔstkΔstp strains than against the wild 
type. The Δstk und ΔstkΔstp strains displayed a 2-fold increased susceptibility to ramoplanin, methicillin and 
penicillin G compared to the wild type strain. The mutation of stk or stp did not affect the MIC of the other tested 
cell wall-active antibiotics such as vancomycin, daptomycin and bacitracin (Table S6).
Figure 4. Interaction network of Stk and Stp as well as FemX/A/B. (a) Stk as well as FemA and FemB formed 
homodimers and interacted with each other and as well as with MurG. For bacterial two-hybrid analysis, 
co-transformants of cya mutant E. coli BTH101 were spotted onto X-gal indicator plates. The blue colour 
after 5 days incubation time at 18 °C indicated the reconstitution of the functional adenylate cyclase due 
to the interaction of the fusion proteins. pKT25-zip/pUT18-zip represented the positive control, whereas 
empty plasmids p25C and p18C represented negative controls. Every interaction was tested in at least three 
independent experiments. (b) Interaction network of Stk, Stp and FemX/A/B proteins among cell wall synthesis 
and cell division proteins as determined by bacterial two-hybrid analysis (Fig. S4). Interaction is indicated by a 
line. Homodimerization of Stk, FemA and FemB is indicated by a circular arrow. (c) Stk phosphorylated FemX 
but did not phosphorylate FemA or FemB in the in vitro kinase assay. Stp dephosphorylated Stk-dependent 
phosphopeptides of FemX. The upper panel shows a loading control stained with Coomassie-blue; the bottom 
panel shows a Western blot of phosphorylated proteins using an anti-phosphothreonine antibody (αP-Thr).
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Discussion
Proper cell wall synthesis is essential to protect bacteria against the extracellular environment and for resisting 
high intracellular turgor. Synthesis of the cell wall is a complex and highly coordinated process both temporally 
and spatially. Although the major components of bacterial cell walls have been known for decades, many details 
of the complex regulatory network controlling PGN synthesis and the cell division machinery are not well under-
stood and are a topic of current research7. In particular, the regulatory impact and interplay of two-component 
systems such as VraRS, GraSR, WalKR and the role of the eukaryotic-like serine/threonine kinase Stk and its 
associated phosphatase Stp remains to be discovered. Several former studies suggest an important role of Stk in 
cell wall metabolism11, cell division and autolysis10.
In this report we provide evidence that both the kinase Stk and the phosphatase Stp are involved in the regu-
lation of cell wall synthesis. Notably, stp deletion had a more pronounced impact on the cell wall than deletion of 
stk. Most strikingly, in the Δstp mutant, the cell wall was thicker and incorporated higher amounts of incomplete 
muropeptides. The thick cell wall phenotype of Δstp was previously reported for several MRSA strains such as 
N31510, MW222 and a clinical USA300 isolate17. The molecular mechanisms leading to this phenotype seem to be 
manifold as mutations in multiple regulatory pathways such as vraSR34, graSR34, walKR34, and stk/stp17 and lack 
of nutrients like glycine depletion35 have been linked to this phenotype. However, the exact mechanism remains 
unclear.
In our study, we determined the cell wall composition of S. aureus wild type and Δstk, Δstp and ΔstkΔstp 
mutants, which revealed that Δstp incorporated higher amounts of incomplete muropeptides. These incom-
plete muropeptides had non-glycine, monoglycine and monoalanine interpeptide bridges in the cell wall of sta-
tionary phase cells. Interestingly, a similar unexpected cell wall phenotype was observed by Monteiro in a S. 
aureus mutant strain expressing FemX with a C-terminal fusion of GFP. This FemX-GFP mutant strain shows 
a decreased FemX enzyme activity leading to an altered cell wall composition with an increase of incomplete 
muropeptides and decrease of pentaglycine-containing muropeptides36. FemX catalyzes the introduction of the 
first glycine of the pentaglycine cross bridge to lipid II. FemX deletion mutants are not viable37, therefore the 
FemX-GFP mutant has to exert residual enzymatic activity. A conditional femX repression leads to accumulation 
of less-crosslinked, unmodified muropeptides38. In contrast to FemX, the subsequent enzymes FemA or FemB are 
non-essential. A femA and femB deletion led to accumulation of monoglycine or triglycine muropeptides, respec-
tively39,40 which decreased the interpeptide cross-linking in the PGN sacculus as compared to wild type cells41. 
Surprisingly, the accumulation of incomplete muropeptides in the stp deletion strain did not affect the amount 
of interpeptide cross-linking. However, the observed structural changes within the interpeptide bridges are a 
plausible explanation why the stp mutant was less susceptible to lysostaphin. As lysostaphin cuts the pentaglycine 
bridge between the third and the fourth glycine42, changes in the amino acid composition affect the cleavage 
of the interpeptide bridge. Importantly, we showed that Stk phosphorylates and Stp dephosphorylates FemX. 
Mass spectrometric analysis identified Thr32, Thr36 and Ser415 of FemX as phosphoacceptors. Surprisingly, Stk 
interacted with FemA and FemB in bacterial two-hybrid studies, but was unable to phosphorylate them in vitro. 
FemA-FemB interaction as well as homodimerization of both proteins were consistent with previous results43. 
Unlike FemA/B proteins, FemX interacted neither with Stk nor with FemA/B proteins nor with itself in the bacte-
rial two-hybrid studies. Despite this missing direct interaction between Stk and FemX in the bacterial two-hybrid 
studies, the in vitro kinase/phosphatase assay suggests an interaction of Stk/Stp with FemX. We hypothesize that 
regulation of FemX activity by Stk/Stp is the reason for the altered muropeptide composition in the stp mutant 
strain. A realistic scenario could be a phosphorylation-mediated inhibition of FemX activity, which reduces the 
following cell wall synthesis steps.
Due to the Stk-FemX/A/B interaction profile, we were interested in potential interaction partners of Stk in cell 
wall synthesis and cell division. In our two-hybrid interaction studies, Stk also interacted with cell wall synthesis 
enzymes (MurG, FemA/B), PGN cross-linking enzymes (Pbp1-3, RodA, FtsW), as well as the cell wall hydrolase 
LytH and the monofunctional transglycosylase Mgt. The amidase LytH is predicted in the database aureowiki to 
be N-terminally anchored in the membrane where Stk could interact with LytH. Taken together this indicates 
a Stk-dependent regulation of cell wall remodelling. This is in line with observations in other bacteria in which 
Stk homologs interact with and phosphorylate penicillin-binding proteins like PBP2x28, PBP232 and PBPA44. The 
interactions of Stk with Pbp1-3, RodA, FtsW and septal cell division proteins (DivIB, DivIC, EzrA) fit well to the 
septal localization of Stk9. The current model of Stk activation implies that the PASTA domains mediate the septal 
localization9 and induce Stk dimerization45. In line with this model, we confirmed Stk dimerization by use of the 
bacterial two-hybrid system. Following dimerization, S. aureus Stk, and also its homologs in other pathogens, are 
autophosphorylated as has been proven in vitro10,12. Dephosphorylation of Stk is mediated by direct interaction 
with the cognate phosphatase Stp in vitro. In contrast to Stk, Stp did not interact with any other tested protein in 
our bacterial two-hybrid studies except for the weak interaction with Stk. Nevertheless, the in vitro dephosphoryl-
ation assay indicate a direct interaction of Stp with Stk and FemX. Probably, the missing Stp-interactions in bac-
terial two-hybrid is due to technical reasons, as potential targets of Stp are not phosphorylated under the tested 
conditions. Furthermore, it should be noted that this bacterial two-hybrid analysis was done in a heterologous 
expression system, which may influence membrane integration and processing of proteins.
Our metabolome data add further insights into a phosphorylation-dependent regulation of PGN precursor 
synthesis enzymes by Stk/Stp. Both Stk and Stp had the strongest effects on activity of MurC and MurE/F, consid-
ering the increase or decrease of the respective metabolites in the mutant strains. In spite of metabolic changes, 
Stk and Stp did not interact with the cytosolic cell wall synthesis enzymes (GlmS/M/U, MurA-F) in our bacterial 
two-hybrid studies. Nevertheless, in vivo serine and threonine phosphorylation sites of staphylococcal GlmM46 
and MurD47 clearly indicate a regulation of these enzymes by phosphorylation. Furthermore, other studies 
showed that the Stk homologs in streptococci and mycobacteria regulate the cell wall synthesis enzymes GlmM26, 
GlmU48 and MurC27 and interact with the Mur synthetases MurC-F49. Moreover, in Mycobacterium tuberculosis 
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the activity of these cytosolic cell wall synthesis enzymes is regulated by the Stk homolog PknB through phospho-
rylation of co-factors like CwlM and Wag3150,51. Interestingly, Stk interacted with the membrane-located cell wall 
synthesis enzyme MurG but not with MraY. Nevertheless, the detected in vivo phosphorylation site of MraY47 and 
a decreased tunicamycin sensitivity of the mutant strains indicate Stk-/Stp-dependent regulation. All these data 
support the idea that Stk/Stp regulates cell wall synthesis and cell division at multiple layers. However, Stk/Stp 
dependent regulation does not act as on/off system but rather fine-tunes activity of components of the cell wall 
synthesis and cell division machinery to ensure efficient cell wall synthesis.
In our proposed model (Fig. 5), Stk is activated through PASTA domain-dependent binding of accumulated 
pentaglycine-lipid II9 during cell wall stress or growth arrest. Then, active Stk phosphorylates FemX and other cell 
wall synthesis enzymes. This leads to a reduction of cell wall synthesis and could be a physiological feedback loop 
for cell wall synthesis. The phosphatase Stp activates cell wall synthesis enzymes like FemX through dephospho-
rylation of Stk-mediated phosphorylation sites (Fig. 5a,b). This model is supported by the physiological changes 
observed in the stp mutant. The Stp-deficient cells are not able to dephosphorylate FemX, resulting in perma-
nently phosphorylated FemX. In consequence, this less active FemX reduces pentaglycine interpeptide bridge 
formation of lipid II which results in the incorporation of incomplete muropeptides into the PGN sacculus. The 
cells likely compensate for the altered PGN composition by increasing cell wall thickness (Fig. 5c). Based on these 
results, phosphatase inhibitors may be developed as promising antibacterial agents that induce deregulation of 
bacterial cell wall metabolism and, in combination with cell wall-active antibiotics, could overcome the current 
shortage in the treatment of S. aureus and other bacteria.
Methods
Strains, media and growth conditions. The strains and plasmids used in this study are listed in 
Tables S8–12. S. aureus NewmanHG (NewHG)52 strains were grown in Tryptic soy broth (TSB, HiMedia, India) 
and E. coli strains in lysogenic broth (LB). The bacteria were shaken at 180 rpm and 37 °C, unless indicated 
otherwise.
Construction of S. aureus NewmanHG Δstk, Δstp and ΔstkΔstp strains. The S. aureus 
NewmanHG mutant strains lacking stk, stp or both stk and stp genes were constructed as previously described 
for S. aureus 8325 ΔpknB12. Briefly, fragments upstream and downstream of stk, stp and stk/stp were amplified 
by PCR using listed primers (Table S11). The erythromycin resistance cassette (ermB, 1346 bp) was amplified 
from the pEC153 using ermB primers (Table S11). The fragments were cloned into the pGEM-T vector (Promega, 
Mannheim, Germany) and then cut out with the corresponding restriction enzymes and cloned into the 
temperature-sensitive shuttle pBT2. These vector constructs were electroporated into S. aureus RN4220, trans-
duced to S. aureus NewmanHG via phage Φ85, and chromosomally integrated after temperature shift. The dele-
tions were verified by PCR using gene-specific primers and S. aureus Genotyping Kit 2.0 (Alere, Jena, Germany).
Figure 5. Model for Stk-/Stp-dependent regulation of cell wall synthesis protein FemX. (a) During regular 
growth, the kinase Stk is not phosphorylated and less active. Hence, the phosphatase Stp dephosphorylates 
the Stk-target FemX and other cell wall synthesis enzymes. (b) Following cell growth arrest due to nutrient 
depletion, accumulated pentaglycine-lipid II activates Stk through PASTA domain-dependent binding9. 
Active Stk phosphorylates FemX and other cell wall synthesis enzymes, leading to downregulation of cell 
wall synthesis. (c) In the stp deletion strain, phosphorylated Stk-target proteins like FemX cannot be reversed 
by dephosphorylation and in consequence accumulate in the cell. This increases the concentration of PGN 
precursors and incomplete muropeptides are incorporated into the cell wall, resulting in a thicker cell wall and 
reduced lysostaphin sensitivity.
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Transmission electron microscopy. For transmission electron microscopy (TEM), the strains were grown 
in 20 ml TSB medium at 37 °C. The optical density (OD600) of the culture was measured at 600 nm. 15 ml of 
late logarithmic (OD600 2) and 1 ml of stationary phase culture (overnight, OD600 10) were centrifuged (10 min, 
8,000 × g) and the cell pellet was fixed in 2.5% glutaraldehyde buffered in cacodylate buffer for 30 min on ice. 
Further electron microscopy sample preparation processing was conducted according to Prüfert et al.54. Electron 
micrographs were recorded at 200 kV acceleration voltage on a JEM-2100 electron microscope (JEOL, Freising, 
Germany) with the digital camera TemCam F416 (TVIPS, Gauting, Germany). The mean cell diameter (CD) and 
the cell wall thickness (CWT) of S. aureus wt and mutant cells based on the diameter of the 20 largest cells out 
of 100 cells per strain at five different spots on the cell wall. We chose the 20 largest cells without septa to ensure 
that all cells are in the same stage of the cell cycle. Significance values of CD and CWT were calculated using a 
two-tailed unpaired student t-test (*p < 0.05, **p < 0.01, ***p < 0.001).
Analysis of muropeptide profiles. The strains were grown at 37 °C in 20 ml TSB medium to an OD600 of 
2 (late logarithmic growth phase) and overnight (OD600 9 to 12, stationary growth phase). Four ml of logarithmic 
phase culture or 2 ml of stationary phase culture were centrifuged (20 min, 5,000 × g) and the cell pellets were 
stored at −80 °C. PGN was isolated as previously described55 with the following exceptions: (1) For digestion into 
muropeptides 100 µl of the resuspended PGN (OD600 = 3) were incubated with 20 µl mutanolysin (2,000 U/ml) 
for 21 h at 37 °C on a magnetic stirrer. (2) For UPLC analysis a 100 mM sodium phosphate buffer with pH 2.5 
(buffer A), instead of TFA, was used in a linear gradient from 95% buffer A and 5% methanol to 70% buffer A and 
30% methanol in 70 min with a flow rate of 0.167 ml/min at 52 °C column temperature. UPLC-MS was performed 
exactly as describe previously55. Muropeptides were determined by their retention times and their masses. The 
amounts given are the relative abundances of the respective peak area as percentage of all muropeptide peaks. The 
mean and standard deviation was calculated as integral under the peak in comparison to integral of the whole 
chromatogram. The muropeptide interpeptide cross-linking was calculated according to following formula5.
= + + +cross linking [%] 1/2 dimer 2/3 trimer 3/4 tetramer 9/10 oligomer
Lysostaphin susceptibility assay. The strains were grown at 37 °C TSB medium to an OD600 of 2 (late 
logarithmic growth phase) and overnight (OD600 5 to 7, stationary growth phase). The cultures of S. aureus strains 
were adjusted to OD600 of 2, and 1 ml cell suspensions were pelleted. After washing once with 1 ml of lysostaphin 
buffer (20 mM Tris-HCl pH 7, 150 mM NaCl, 1 mM EDTA), the pellets were then resuspended in 1 ml lysostaphin 
buffer. One hundred µl of 1 µg/ml lysostaphin (Bharat Biotech, Hyderabad, India) was added to every 100 µl of 
each bacterial suspension in a 96-well plate and incubated at 37 °C in a microplate reader (TECAN, Maennedorf, 
Switzerland). The OD600 of each culture was read every 5 minutes and plotted as a percentage of the initial reading, 
which was set to 100% and 0 minutes. Significance values of lysostaphin susceptibility were calculated using a 
two-tailed unpaired student t-test (*p < 0.05, **p < 0.01, ***p < 0.001).
Determination of intracellular metabolites. Cell wall precursor concentrations were determined 
according to a recently published protocol11,56. Briefly, 20 OD600 units of the 100 ml TSB cell culture broth of 
logarithmic (OD600 2) and stationary phase (OD600 9 to 12) cells were separated by fast filtration, and the cells 
were washed with 15 ml of 0.6% ice-cold sodium chloride solution. The filter was immediately transferred to a 
tube filled with 5 ml of ice-cold extraction solution (60% [wt/vol] ethanol) and quickly frozen in liquid nitrogen. 
The frozen sample was stored at −80 °C. Every following extraction step was carried out on ice. The bacteria were 
washed off the filter by shaking and vortexing in extraction solution. After centrifugation (10 min, 10,000 rpm 
at 4 °C) the supernatant was transferred into a 50-ml tube containing glass beads with a diameter of 0.1 μm 
(Sigma-Aldrich, Taufkirchen, Germany). After washing the filter with 5 ml ultrapure water (HPLC grade) and 
adding the internal standard for LC-MS analysis (5 nmol camphorsulfonic acid) to the combined cell suspen-
sions, cell disruption was performed by using a FastPrep-24 instrument (MP Biomedicals, Eschwege, Germany) 
twice for 45 s each 6.0 m/s. Cell lysate was separated from cell debris by centrifugation (10 min, 12,000 rpm at 
4 °C) and the supernatant was transferred into a 50-ml tube. The cell debris was washed again with 5 ml ultrapure 
water and a second cell disruption was performed by FastPrep. The supernatants were combined, diluted with 
20 ml ice cold water (HPLC-MS grade) and stored at −80 °C before lyophilization. The lyophilized samples were 
dissolved in 100 µl water and centrifuged (3 min at room temperature). The supernatant was transferred into a 
glass vial. Ion pairing LC-MS measurement and data analysis was performed as previously described57. Changes 
in PGN precursor levels between wild type and mutant strains were compared using the non-parametric unpaired 
Mann-Whitney test. Differences were considered significant when p-value < 0.05.
Bacterial two-hybrid analysis to test protein-protein interaction. Strains and plasmids used in this 
work are listed in Tables S9 and S12. The bait vectors p25N (pKNT25) and p25C (pKT25), the prey vectors p18C 
(pUT18C) and p18N (pUT18), the control plasmids pKT25-zip and pUT18C-zip and the Δcya reporter strain 
E. coli BTH101 were obtained from EuroMedex (Stouffelweyersheim, France). The genes encoding the protein of 
interests are amplified from S. aureus NewmanHG genomic DNA by PCR and fused in-frame to the 3′ (p18N or 
p25N) or 5′ end (p18C or p25C) of the cyaA gene fragment of the appropriate vectors. stk, stp and femX/A/B genes 
were cloned into the bait vector p25C and the prey vector p18C. PGN synthesis- and cell wall division genes were 
cloned into the p18C vector or were a kind gift from S. Foster (Sheffield, UK)58 or D. Lopez (National Centre for 
Biotechnology, Madrid, Spain) (Table S9).
The recombinant plasmids encoding T25- or T18- hybrid proteins are transformed into competent E. coli 
BTH101 reporter cells. Transformants are plated on selective plates (LB agar with 50 µg/ml kanamycin, 100 µg/ml 
ampicillin and streptomycin) and incubated at 30 °C for up to two days. Five to 10 colonies were combined and 
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incubated overnight in LB media with the appropriated antibiotics at 30 °C. Two µl overnight culture was spotted 
on indicator plates (LB agar with appropriated antibiotics, 40 µg/ml X-gal, 0.5 mM IPTG) using a replica plater 
(Sigma-Aldrich, Taufkrichen, Germany) and incubated for 5 days at 18 °C. As a negative control each bait vector 
was tested against an empty prey vector and vice versa. The control plasmids pKT25-zip/pUT18-zip were used as 
a positive control. Each plasmid combination was tested at least three times on indicator plates. The classification 
of protein-protein interactions is based on the time point when the colonies change their colour. The positive 
control (pKT25-zip/pUT18-zip) and positive interactions changed the colour to blue after 2 to 4 days. No interac-
tions showed no colour change after 5 days. If a slight colour change was visible after 5 days, then we interpreted 
this interaction as weak and this interaction should be characterized with another method. We stopped the assay 
after 5 days, when nearly all combinations as well as the negative controls showed a slight background reaction. 
To check the specificity of the interaction, every vector was also tested with their empty partner vector p18C or 
p25C vector. Moreover, we quantified the β-galactosidase activity of selected protein-protein interactions based 
on spot assay at Fig. 4a (Fig. S13).
Cloning, expression and purification of recombinant proteins. The recombinant N-terminal 
polyhistidine-tagged proteins Stp, StkKD, FemX, FemA and FemB were cloned and purified as previously 
reported12. Briefly, the coding sequence of the genes and the coding sequence of the Stk kinase domain (amino 
acid 1 to 291) (StkKD)33 were amplified by PCR using genomic DNA of S. aureus NewmanHG and primers listed 
in Table S11. The gene fragments were restricted with appropriate enzymes and ligated into the pET28a vector 
(Novagen, Wisconsin, USA). This vector was transformed into E. coli BL21 (DE3) cells for protein expression. For 
expression of recombinant proteins, one liter of E. coli cultures were grown at 37 °C until an OD600 of 0.5 to 0.7 
was reached. After adding 0.5 mM final concentration of IPTG, the cells were incubated overnight at 18 °C. The 
cells were harvested (15 min, 4,000 × g, 4 °C) and the cell pellet was stored at −20 °C. The proteins were purified 
under native conditions by affinity chromatography on Proteino Ni-TED columns by following the manufactur-
er’s instructions (Macherey-Nagel, Düren, Germany). Briefly, the cell pellet was resuspended in 10 ml lysis buffer 
(50 mM NaH2PO4, 300 mM NaCl, 50 µg/ml DNase, 100 µg/ml lysozyme, 0.02% Calbiochem Protease Inhibitor 
Cocktail Set 1 [Merck, Darmstadt, Germany]) and incubated 30 min on ice. The cells were sonicated (5 × 45 s) and 
centrifuged (30 min, 8,000 × g, 4 °C). The supernatant was loaded on the Ni-TED columns, and protein purifica-
tion was performed following the manufacturer’s instructions. The eluates were dialyzed in 50 mM Tris-HCl pH 
7.5, 300 mM NaCl and concentrated using Amicon Ultra filter (Merck, Darmstadt, Germany). Protein concentra-
tion was determined by Advanced Protein Assay (Cytoskeleton, Denver, USA).
In vitro phosphorylation/dephosphorylation assay. One µg recombinant proteins (FemX, FemA or 
FemB) were incubated with 1 µg Stk kinase domain (StkKD) in kinase buffer (50 mM Tris-HCl pH 7.5, 3 mM 
MgCl2, 3 mM MnCl2) with or without 20 mM ATP for 1 h at 37 °C. For the dephosphorlyation reaction, 1 µg Stp 
was added to the reaction mixture. Each reaction was stopped by addition of 5 x SDS sample buffer and heating 
for 5 min 95 °C. The phosphorylated proteins were detected by Western blotting using an anti-phosphothreonine 
antibody (#9381 S, Cell Signaling, Frankfurt, Germany). SDS-PAGE was performed and the proteins were blot-
ted on a nitrocellulose membrane using a semi-dry blotting technique. The blot was blocked in 5% albumin 
(Sigma-Aldrich, Taufkirchen, Germany) in TBS (10 mM Tris-HCl pH 7.5, 0.9% NaCl) for 2 h and then incubated 
with anti-phosphothreonine antibody (1:5,000, 1% albumin/TBS-T) overnight at 4 °C. After washing the blot 
three times in TBS-T (TBS + 0.05% Tween 20) for 15 min, the blot was incubated with anti-rabbit-HRP antibody 
(#L3012, SAB, USA) (1:10,000 in TBS) for 2 h. After three additional TBS-T washing steps, the blot was incubated 
with ECL substrate for 2 min. Phosphorylated proteins were visualized using ImageQuant LAS 4000 imaging 
system (GE Healtcare, Munich, Germany).
Mass Spectrometry. In order to characterize phosphorylation sites of the FemX/A/B proteins, we per-
formed mass spectrometry. The in vitro phosphorylation/dephosphorlyation reaction was stopped by heating 
the sample for 5 min at 95 °C. The sample was then reduced for 30 min with 1 mM dithiothreitol and alkylated 
for 30 min in the dark with 10 mM iodoacetamide. After adding 5x SDS sample buffer and heating the sample for 
5 min at 95 °C, SDS-PAGE was performed. The corresponding protein bands of the Coomassie-stained SDS-gel 
were cut out and destained with 30% acetonitrile in 0.1 M NH4HCO3 (pH 8), shrunk with 100% acetonitrile and 
dried in a vacuum concentrator (Concentrator 5301, Eppendorf, Germany). Digests were performed with 0.1 µg 
elastase per gel band overnight at 37 °C in 0.1 M NH4HCO3 (pH 8). After removing the supernatant, peptides 
were extracted from the gel slices with 5% formic acid, and extracted peptides were pooled with the supernatant.
NanoLC-MS/MS analyses were performed on an Orbitrap Fusion (Thermo Scientific) equipped with a 
PicoView Ion Source (New Objective) and coupled to an EASY-nLC 1000 (Thermo Scientific). Peptides were 
loaded on capillary columns (PicoFrit, 30 cm × 150 µm ID, New Objective) self-packed with ReproSil-Pur 120 
C18-AQ, 1.9 µm (Dr. Maisch, Ammerbuch-Entringen, Germany) and separated with a 30-minute linear gradient 
from 3% to 30% acetonitrile and 0.1% formic acid and a flow rate of 500 nl/min.
Both MS and MS/MS scans were acquired in the Orbitrap analyser with a resolution of 60,000 for MS scans 
and 15,000 for MS/MS scans. HCD fragmentation with 35% normalized collision energy was applied. Triply 
and higher charged precursors were also selected for ETD fragmentation using EasyETD option. A Top Speed 
data-dependent MS/MS method with a fixed cycle time of 3 seconds was used. Dynamic exclusion was applied 
with a repeat count of 1 and an exclusion duration of 120 seconds; singly charged precursors were excluded from 
selection. Minimum signal threshold for precursor selection was set to 50,000. Predictive AGC was used with 
AGC a target value of 5e5 for MS scans and 5e4 for MS/MS scans. EASY-IC was used for internal calibration.
Data analysis was performed with PEAKS Studio 8.0 with the following parameters: parent mass error toler-
ance: 8 ppm, fragment mass error tolerance: 0.02 Da, enzyme: none, variable modifications: pyro-Glu (N-term. 
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Q), oxidation (M), carbamidomethyl (C), phosphorylation (STY), acetylation (protein N-term.), max. variable 
modifications per peptide: 3. Database search was performed against a custom database containing the sequence 
of the FemX/A/B, Stk and Stp. Results were filtered to 1% FDR on the peptide level.
Antibiotic susceptibility testing. Minimal inhibitory concentrations (MIC) of all listed antibiotics 
(Fig. S6) were determined by microdilution according to the recommendations of the Clinical and Laboratory 
Standard Institute guidelines59. The MICs were determined in 96-well microtiter plates using a final volume of 
200 µl TSB media, starting with an initial inoculum of OD600 0.05 per well. Plates were incubated for 24 h at 37 °C.
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